Industry News

Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, today pledged to donate up to $100,000 in matching funds to the Orthopaedic Research and Education Foundation. According to the agreement, Zimmer Biomet will help underwrite OREF's grant administration costs by donating 10 cents for every dollar given to OREF by individual donors. Since 2010, Zimmer Biomet has donated more than $6 million toward..."/>
Zimmer Biomet Contributes Additional $100,000 in Funding to the Orthopaedic Research and Education Foundation
Accuray CyberKnife ® and TomoTherapy ® Systems will be shared by leading radiation oncology practitioners, and the Company's new, innovative radiation therapy treatment delivery system, the Radixact™ System, and treatment planning software, will be unveiled at the 2016 ASTRO Annual Meeting in Boston, Massachusetts, September 25– 28, 2016. ASTRO is the world's most important meeting for the radiation oncology..."/>
Accuray to Unveil New Technology at the ASTRO 2016 Annual Meeting
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, today announced that Howie Rosen, chief executive officer, will be presenting at the Ladenburg Thalmann 2016 Healthcare Conference. Details of the event are as follows:. Ladenburg Thalmann 2016 Healthcare Conference Date: Tuesday,..."/>
AcelRx Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Navidea Biopharmaceuticals, Inc. has announced it will receive payments totaling $1 million from two recently achieved Lymphoseek ® commercial milestones under its distribution agreements with U.S. partner Cardinal Health,..."/>
Navidea Achieves $1 Million in Lymphoseek® Commercial Milestones
Lannett Company, Inc. today announced the resignation of its chief of scientific affairs, Mahendra Dedhiya, Ph.D., effective October 21, 2016.. "Mahendra joined Lannett last year as part of our acquisition of Silarx Pharmaceuticals," said Arthur Bedrosian, chief executive officer of Lannett. "He intends to become a faculty member and researcher at Long Island University, where he had been teaching part time."/>
Lannett Announces Resignation Of Mahendra Dedhiya, Ph.D., Chief Of Scientific Affairs
UnitedHealth Group will release its financial results for the third quarter of 2016 on Tuesday, October 18, 2016, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investors page of the company’ s web site. The replay will be available on the web site or by dialing 1-800-283-4799 through November 1.."/>
UnitedHealth Group Schedules Third Quarter Earnings Release and Conference Call for October 18, 2016
Quest Diagnostics stated on Wednesday that it has introduced its new antibody test service that aids the diagnosis of infection with the Zika virus, an infectious disease spread through the bite of infected mosquitoes, from mother to fetus during pregnancy and through sexual transmission. Based on the Zika Immunoglobulin M Antibody Capture Enzyme-Linked Immunosorbent Assay, the new antibody test service was developed by the Centers for..."/>
Quest Diagnostics announces Zika Antibody Test Service in the US as well as Puerto Rico and other US territories
Antibe Therapeutics Inc., a commercial-stage pharmaceutical growth company, continues to demonstrate the anti-cancer potential of its lead drug, ATB-346. In a separate study earlier this year, ATB-346 was shown to be very effective in reversing colon and intestinal tumour growth in mice. Further to this study, a new publication has shown promising results in the chemoprevention and treatment of melanoma in mice."/>
ATB-346 Shows Promising Results in Experimental Melanoma
TherapeuticsMD, Inc., an innovative women’ s healthcare company, today announced the schedule of nine posters and oral presentations at upcoming medical conferences related to Yuvvexy, the conditionally-approved trade name for TX-004HR, an investigational..."/>
TherapeuticsMD Announces Multiple Presentations Related to Yuvvexy™ (TX-004HR) at Two Upcoming Medical Conferences
ChromaDex Corp., an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions to dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced leading supplement retailer, Vitamin Shoppe, featured NIAGEN ® nicotinamide riboside in their Hot Ingredient..."/>
Leading Supplement Retailer Features NIAGEN® as Their Hot Ingredient for Fall, 2016
Agilent Technologies declared on Wednesday that it will pay a quarterly dividend of USD0.115 per share of its common stock. This dividend is payable on 26 October 2016 to all shareholders of record at of the close of business as of 4 October 2016.. In conjunction with the declaration, the company stated that timing and amounts of future dividends are subject to determination and approval by its board."/>
Agilent Technologies sets dividend payment date of 26 October 2016
DaVita Kidney Care, a division of DaVita Inc., a leading provider of kidney care services in the United States, today announced the release of its "Slow Cooker Recipes" cookbook, a collection of kidney-friendly recipes that allow those on a kidney diet to have a delicious meal waiting for them when they get home while reducing time spent in the kitchen. This cookbook utilizes healthy ingredients that minimize potassium, phosphorus and sodium while..."/>
DaVita Kidney Care Celebrates First Day of Autumn with Slow Cooker Cookbook
ViewRay reported on Wednesday the purchase of its MRIdian System, an clinical MRI-guided radiation therapy, by the National Cancer Center in Tokyo, Japan. According to the company, the MRIdian System is the world's first and only clinical MRI-guided radiation therapy system. It is a unique medical instrument that integrates full-time MR imaging, cobalt radiation delivery and intelligent software automation."/>
ViewRay announces sale of first MRIdian in Japan following Shonin approval
Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular disease, and NAFLD/NASH, today announced that Mina Sooch, President and Chief Executive Officer, will present a corporate overview at the Ladenburg Thalmann 2016 Healthcare Conference, being held..."/>
Gemphire Therapeutics to Present Corporate Overview at the Ladenburg Thalmann 2016 Healthcare Conference
OrganiGram Holdings Inc. is pleased to announce that it has successfully amended its Health Canada licensed sales capacity of dried marijuana to 1,200 kg per annum. Additionally, Health Canada also increased OrganiGram's licensed production and sales capacity for cannabis oils to 500 kg per annum. "OrganiGram has worked cooperatively with patients, physicians, and the regulators to ensure that our clients and counterparties can continue to..."/>
OrganiGram's License Capacity Increased by Health Canada
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced that results from a Category 3 oral human abuse potential study and a Category 3 intranasal HAP study of product candidate ARYMO™ ER extended-release tablets have been published in Pain Medicine, the official journal of the American..."/>
Egalet Announces Publications in Pain Medicine from ARYMO™ ER Oral and Intranasal Human Abuse Potential Studies
BIOLASE, Inc., the global leader in dental lasers, announced today that veteran international dental sales and business development executive Holger Arens has been named to the newly-created position of Vice President and Managing Director for Europe, the Middle East and Africa, effective immediately. Arens is based in Germany and will report..."/>
BIOLASE Names Holger Arens Vice President, Managing Director EMEA
Skyline Medical reported on Wednesday the launch of a partnership and exclusive reseller agreement with GLG Pharma. This partnership allows GLG to develop rapid diagnostic tests that utilise fluid and tissue collected by Skyline's STREAMWAY System during procedures. In conjunction with the agreement, Skyline Medical will issue common stock to GLG in four separate tranches, with each tranche released after the achievement of certain..."/>
Skyline Medical partners with GLG Pharma to develop diagnostic tests for STREAMWAY System
Apricus Biosciences on Wednesday reported the availability of its novel on-demand topical cream for the treatment of erectile dysfunction, Vitaros, in the Czech Republic and Slovakia. The company said Vitaros will be marketed by Recordati under a exclusive license agreement. Pursuant to the agreement, Apricus is eligible to receive up to approximately USD39.7m from Recordati in additional milestones, plus double-digit tiered royalties in the..."/>
Apricus Biosciences unveils Vitaros in the Czech Republic and Slovakia via Recordati
MYnd Analytics, will present“ Disruptive Technology Gets Personal” on September 25, 2016 at the Annual Conference of the American College of Private Physicians.. The presentation will focus on the use of predictive analytics to guide medication selection."/>
Dr. Mark Schiller to present PEER at American College of Private Physicians
Enzo Biochem Assay Platform, Further Underscoring Growing Importance of Company's Clinically Relevant Diagnostics. NEW YORK, NY- Enzo Biochem, Inc. today announced that the New York State Department of Health has granted conditional approval for use of Enzo Clinical Labs' PLAQPRO (TM) Lp-PLA2 Assay. This cardiac assay delivers improved consistency and is designed to work on open platform clinical analysis instruments."/>
Enzo Biochem Announces New York State Health Department Approval of New Easily Adaptable, Cost Effective Cardiac Assay

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology609 Articles
Consumer Discretionary560 Articles
Financials368 Articles
Industrials342 Articles
Health Care338 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at